The influence of new quinolones on blood glucose level

Japanese Journal of Chemotherapy

Volumn 44, Issue 10, 1996, Pages 798-803

  Sakurai, Iwao ^a   Yoshida, Masaki ^a   Ishida, Yuichiro ^a   Matsumoto, Fumio ^a   Takahashi, Takayuki ^a   Morita, Masayuki ^a   Ueda, Yasushi ^b  

^a Kanagawa Prefecture Midwives and Nurses Training School Hospital   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

enoxacin; insulin

Indexed keywords

BUNAZOSIN; C PEPTIDE; CIPROFLOXACIN; ENOXACIN; GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEVOFLOXACIN; LOMEFLOXACIN; NEW DRUG; NICERGOLINE; NORFLOXACIN; PRAZOSIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEMAFLOXACIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; MALE; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST;

EID: 0029855355     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Smith G D, Amos TAS, Mahler R, Peters T J: Effect of chloroquine on insulin and glucose homeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus. Br Med J 294: 465-467, 1987
2. Tack K J, Smith J A: The Profile of Ofloxacin. Amer J Med 87 (suppl 6C) : 78s-81s, 1989
3. Burton T M: Adverse patient reactions force abott to pull new antibiotic from market. The Wall Street Journal, June 8, 1992